Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-26-050231
Filing Date
2026-04-30
Accepted
2026-04-30 16:12:08
Documents
16
Period of Report
2026-06-26

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0287703-01.htm   iXBRL DEF 14A 1049844
4 GRAPHIC tallarity_logo.jpg GRAPHIC 57631
5 GRAPHIC tproxy_001.jpg GRAPHIC 1579880
6 GRAPHIC tproxy_002.jpg GRAPHIC 1454639
  Complete submission text file 0001213900-26-050231.txt   8774099

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE allr-20251231.xsd EX-101.SCH 1427
3 XBRL LABEL FILE allr-20251231_lab.xml EX-101.LAB 439
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0287703-01_htm.xml XML 8574
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41160 | Film No.: 26925432
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)